Adverse effects of remdesivir, hydroxychloroquine and lopinavir/ritonavir when used for COVID-19: systematic review and meta-analysis of randomised trials, BMJ Open
Review (16 RCTs;n=8152) found hydroxychloroquine(HQ) probably& lopinavir/ritonavir may increase risk of diarrhoea& nausea&/or vomiting. HQ probably increases cardiotoxicity risk& cognitive dysfunction/delirium(CD/D). Remdesivir may have no important effect on AKI risk or CD/D. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - March 4, 2022 Category: Consumer Health News Source Type: news
India-made stimulants, COVID-related drugs dominate illegal imports in Switzerland
A large number of illegally imported drugs in Switzerland have been found to have been sent from India, including medicines connected with the COVID-19 pandemic including ivermectin and hydroxychloroquine as also erectile stimulants, a Swiss government agency said (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 21, 2022 Category: Pharmaceuticals Source Type: news
New Ivermectin, HCQ Scripts Highest in GOP-Dominated Counties New Ivermectin, HCQ Scripts Highest in GOP-Dominated Counties
Rates of new hydroxychloroquine (HCQ) prescriptions particularly increased in highly Republican counties after the Food and Drug Administration revoked its EUA for the drug ' s use in treating COVID-19.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - February 18, 2022 Category: Cardiology Tags: Infectious Diseases News Source Type: news
Study: Political affiliation spurred hydroxychloroquine, ivermectin use for COVID-19
Regions of the United States that voted Republican in the 2020 presidential election saw far more more hydroxychloroquine and ivermectin prescriptions written for people with COVID-19 than in Democratic areas. (Source: Health News - UPI.com)
Source: Health News - UPI.com - February 18, 2022 Category: Consumer Health News Source Type: news
Oklahoma AG OKs Prescribing Ivermectin, Hydroxychloroquine Oklahoma AG OKs Prescribing Ivermectin, Hydroxychloroquine
Oklahoma ' s attorney general says his office has found no legal basis for medical boards to discipline doctors who prescribe ivermectin or hydroxychloroquine for COVID-19.Associated Press (Source: Medscape Infectious Diseases Headlines)
Source: Medscape Infectious Diseases Headlines - February 9, 2022 Category: Infectious Diseases Tags: Infectious Diseases News Source Type: news
Concern as Republicans push to make dubious Covid cure prescriptions easier
Ivermectin and hydroxychloroquine, the cures in question, have proven to be ineffective in preventing or treating Covid-19Republican state lawmakers across the United States have proposed – and in some cases passed – legislation that they say keeps the government from interfering with doctors who want to prescribe ivermectin and hydroxychloroquine to help prevent and treat Covid-19.But those treatments have not proven effective at preventing or treating Covid and infectious disease experts see the bills as examples of right-wing lawmakers politicizing medicine – a trend that is increasing as the pandemic wears on in ...
Source: Guardian Unlimited Science - January 30, 2022 Category: Science Authors: Eric Berger Tags: Republicans US news Kansas Coronavirus Science Infectious diseases Source Type: news
Does a new study really show that hydroxychloroquine might be effective against omicron?
The researchers conclude, as many others have, that antibodies (the proteins that neutralise the virus) against previous variants or induced by vaccines are less effective against omicron. What's interesting, though, is that the study finds that omicron may have changed the way it enters cells. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 17, 2022 Category: Pharmaceuticals Source Type: news
The future is bright for RWE in pharma approvals
Real-world evidence (RWE) could help pharma achieve many things – including understanding disease burden better and smarter monitoring of newly marketed therapies to make them safer and more effective. But the most promising near-term use case for RWE, according to a Deloitte survey of pharma executives, is in support of regulatory submissions and label expans ion. For industry stakeholders such as Marc Berger, M.D., this advance is a long time coming. The founder of the real-world data (RWD) and analytics group at Pfizer, Berger has been a contributing author on dozens of policy papers on the use of RWE – including ...
Source: EyeForPharma - January 6, 2022 Category: Pharmaceuticals Authors: Brian Eastwood Source Type: news
‘Magic’ Weight-Loss Pills and Covid Cures: Dr. Oz Under the Microscope
The celebrity physician, a candidate in Pennsylvania ’s Republican primary for Senate, has a long history of dispensing dubious medical advice on his daytime show and on Fox News. (Source: NYT Health)
Source: NYT Health - December 26, 2021 Category: Consumer Health News Authors: Trip Gabriel Tags: The Dr. Oz Show (TV Program) Oz, Mehmet C Pennsylvania Elections, Senate Coronavirus Risks and Safety Concerns Coronavirus (2019-nCoV) Rumors and Misinformation Hydroxychloroquine (Drug) Source Type: news
SARS-CoV2 in a Lupus Patient Treated With Hydroxychloroquine SARS-CoV2 in a Lupus Patient Treated With Hydroxychloroquine
Was this COVID-19 patient ' s decreased immune response a result of his being treated with hydroxychloroquine for lupus?Journal of Medical Case Reports (Source: Medscape Critical Care Headlines)
Source: Medscape Critical Care Headlines - December 21, 2021 Category: Intensive Care Tags: Family Medicine/Primary Care Journal Article Source Type: news
Outgoing NIH director says Trump and other Republicans pressured him to endorse unproven Covid-19 remedies and to fire Fauci
The outgoing director of the National Institutes of Health said Sunday that he faced political pressure from then-President Donald Trump and other Republicans to endorse unproven Covid-19 remedies... #donaldtrump #anthonyfauci #nih #hydroxychloroquine (Source: Reuters: Health)
Source: Reuters: Health - December 19, 2021 Category: Consumer Health News Source Type: news
Raising public awareness about the misuse of predatory journals: one year after the "hydroxychloroquine and push-scooters accidents" hoax [letter] - Rebeaud ME, Cova F, Ruggeri V, Rochoy M.
[The publisher has not provided an abstract for this article.]
Language: en... (Source: SafetyLit)
Source: SafetyLit - November 29, 2021 Category: International Medicine & Public Health Tags: Media, Marketing, and Internet Issues Source Type: news
Chloroquine/hydroxychloroquine use and suicide risk: hypotheses for confluent etiopathogenetic mechanisms? - Costanza A, Placenti V, Amerio A, Aguglia A, Serafini G, Amore M, Macchiarulo E, Branca F, Merli R, Bondolfi G, Nguyen KD.
Chloroquine (CQ) and hydroxychloroquine (HCQ) are classical anti-malarial and anti-inflammatory treatments, which were used as first-line therapy at the beginning of the 2019 coronavirus disease (COVID-19) pandemic. Besides the emerging data on their lack ... (Source: SafetyLit)
Source: SafetyLit - November 29, 2021 Category: International Medicine & Public Health Tags: Poisoning Source Type: news
Biden Nominated a New Food and Drug Administration Head …Finally
President Joe Biden nominated Dr. Robert Califf, a former commissioner of the Food and Drug Administration (FDA) to head the agency again. Biden’s nomination will now go to Congress, which has to confirm Califf.
Since Biden took office, health officials have been waiting for him to appoint a new head after Dr. Stephen Hahn, who was widely criticized by the scientific community for not taking a stronger stand against the Trump Administration’s support of unproven COVID-19 therapies, left the post in January. The FDA is the regulatory agency responsible for reviewing the safety and efficacy of drugs, devices and ...
Source: TIME: Health - November 15, 2021 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized Source Type: news
Lupus in Remission Flares More Often When Reducing, Stopping HCQ Lupus in Remission Flares More Often When Reducing, Stopping HCQ
It ' s clear that more flares occur when patients in remission or low disease activity stop or reduce hydroxychloroquine, but it ' s important to consider this effect in different age groups, too.Medscape Medical News (Source: Medscape Rheumatology Headlines)
Source: Medscape Rheumatology Headlines - November 9, 2021 Category: Rheumatology Tags: Rheumatology News Source Type: news
